Black Swan Analysis had a poster accepted at ISPOR USA 2019 in New Orleans titled “Impact of international reference pricing on five products in the USA”.
International reference pricing (IRP), also known as External Reference Pricing (ERP), is a cost-containment method used internationally to contain drug expenditure. The USA is currently looking to implement IRP. This study aims to estimate the impact on treatment costs of five products by comparing the US wholesaler acquisition cost (WAC) with two possible US IRP scenarios. In this study we found that when taking the Medicare/Medicaid public drug spends for these products, there was an estimated 60-70% saving when using the calculated US IRP versus the WAC price.